There, we enrolled a total of 428 Chinese participants including HCC patients, LC, and BLD cases, and the sample size is more sufficient to elucidate the diagnostic role of PIVKA-II and AFP for Chinese HCC patients. Here, AFP is linked to hepatocellular carcinoma.